baber/WOPTO huggingface dataset:
Patent AU-2012345478-A1 (AU)
Title: A method of generation and transmission of secure tokens based on tokens generated by TRNG and split into shares and the system thereof
Inventor: THOZHUVANOOR VELLAT LAKSHMI
IPC: G09C5/00
Filed: 2012-11-30
Abstract: A method of generating secure tokens and transmission based on (TRNG) generated tokens and split into shares, the method comprising steps of generating the keys by a hardware based True Random number Generator (TRNG); sieving / filtering the generated keys using statistical tests suite and are orthogonal amongst the created; selecting the random numbers of required width as tokens; applying number to image transformation for the said tokens; applying steganography methods of injecting into image carrier to the selected tokens; and splitting the steganographic contents into at least two shares using Share Generation Appliance (SGA), which is based on visual cryptographic methods.
Patent AU-2012358181-A1 (AU)
Title: Compositions and methods for the delivery of biologically active RNAs
Inventor: POLACH KEVIN
IPC: C12N15/115
Filed: 2012-12-24
Abstract: Novel compounds, compositions, and methods for the delivery of biologically active RNA molecules to cells. Specifically, the invention provides novel nucleic acid molecules, polypeptides, and RNA-protein complexes useful for the delivery of biologically active RNAs to cells and polynucleotides encoding the same. The invention also provides vectors for expressing said polynucleotides. In addition, the invention provides cells and compositions comprising the novel compounds and vectors, which can be used as transfection reagents. The invention further provides methods for producing said compounds, vectors, cells, and compositions. Additionally, vectors and methods for delivering biologically active RNA molecules to cells and/or tissues are provided. The novel compounds, vectors, cells, and compositions are useful, for example, in delivering biologically active RNA molecules to cells to modulate target gene expression in the diagnosis, prevention, amelioration, and/or treatment of diseases, discorders, or conditions in a subject or organism.
Patent AU-2013201586-A1 (AU)
Title: Apoptosis signal-regulating kinase inhibitor
Inventor: NOTTE GREGORY
IPC: A61K31/00
Filed: 2013-01-24
Abstract: Attorney Docket No. 874.PF The present invention relates to a compound of formula (I): (I). The compound has apoptosis signal-regulating kinase ("ASK1") inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
Patent AU-2013202789-A1 (AU)
Title: Improved aluminum alloys containing magnesium, silicon, manganese, iron, and copper, and methods for producing same
Inventor: KAMAT RAJEEV
IPC: C22C21/00
Filed: 2013-02-21
Abstract: Attorney Docket No.: 12-0313WO [00477] New HT aluminum alloy bodies and methods of producing the same are disclosed. The new HT aluminum alloy bodies contain 0.20 - 2.0 wt. % Mg, 0.10 - 1.5 wt. % Si, 0.01 - 1.0 wt. % Fe, and, 0.10 - 1.0 wt. % Cu, wherein, when Si+Cu < 0.60 wt. %, then Fe+Mn < 1.5 wt. %, optionally with up to 1.5 wt. % Mn, optionally with up to 1.5 wt. % Zn, wherein at least one of the Mg, the Si, the Fe, the Cu, the optional Mn, and the optional Zn is the predominate alloying element of the aluminum alloy sheet other than the aluminum, and may be produced by preparing the aluminum alloy body for post-solutionizing cold work, cold working by at least 25%, and then thermally treating. The new HT aluminum alloy bodies may realize improved strength and other properties. Page 200 of 200 DEN 98126728v1
Patent AU-2013205503-A1 (AU)
Title: Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
Inventor: GRAY KEVIN A
IPC: C12N9/42
Filed: 2013-04-05
Abstract: 139431_IDOC The invention provides polypeptides having any cellulolytic activity, e.g., a cellulase activity, a endoglucanase, a cellobiohydrolase, a beta-glucosidase, a xylanase, a mannanse, a p xylosidase, an arabinofliranosidase, and/or an oligomerase activity, polynucleotides encoding these 5 polypeptides, and methods of making and using these polynucleotides and polypeptides. In one aspect, the invention is directed to polypeptides having any cellulolytic activity, e.g., a cellulase activity, e.g., endoglucanase, cellobiohydrolase, beta-glucosidase, xylanase, mannanse, p xylosidase, arabinofuranosidase, and/or oligomerase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these 0 polynucleotides and polypeptides. In one aspect, the invention provides polypeptides having an oligomerase activity, e.g., enzymes that convert recalcitrant soluble oligomers to fermentable sugars in the saccharification of biomass. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural, food and feed processing and industrial contexts. The invention also provides compositions or products of manufacture comprising mixtures of enzymes comprising at 5 least one enzyme of this invention.
Patent AU-2013206387-A1 (AU)
Title: Trampoline
Inventor: SCHAFFER JONATHAN MICHAEL
IPC: A63B5/11
Filed: 2013-06-18
Abstract: A trampoline comprises a trampoline sheet or mat supported around its periphery from a circumextending support structure by spring couplings, preferably a plurality of 5 helical springs, under tension. The trampoline is provided with a net enclosure in which a generally circumextending net is mounted by respective sheaths on a plurality of poles coupled to the support structure and extending generally upright therefrom. In use, for the greater part of its height, the position of the net corresponds generally to the periphery of the support structure, while lower edge regions of the net are coupled to 10 the periphery of the sheet or mat inboard of the support structure, thereby at least largely preventing a user from falling or treading upon the spring couplings or on an annular pad overlying said couplings, if present. % 14 17-8 5 2 1 25--- 27 2 23, 17 85 31 32 2
Patent AU-2013213885-A1 (AU)
Title: Stoppers for structures attached to hybrid riser towers
Inventor: VIELLARD BRICE
IPC: E21B17/01
Filed: 2013-01-30
Abstract: A coated or sleeved pipe for a hybrid riser tower has at least one stop formation that is integral with or attached to an external coating or sleeve of the pipe. The stop formation is arranged to restrain movement along the pipe of a structure attached to the pipe, such as a guide frame.
Patent AU-2013237515-A1 (AU)
Title: Method of manufacturing a cartridge for a fluid treatment system
Inventor: TASZAREK JOSEF
IPC: C02F1/00
Filed: 2013-03-20
Abstract: A method of manufacturing a cartridge (104;204;304;404;504;604;704;804) for a fluid treatment system(101;401), wherein the cartridge (104;204;304;404;504;604;704;804) includes a housing defining at least one chamber for a fluid treatment medium, includes providing a cartridge housing part (212;312;512;612;712;812) including at least one wall (217;313;517;613;713;813) defining at least one opening (218;318;518;618;718;818) closable by a filter element (219;319;519;619;719;819). The filter element (219;319;519;619;719;819) is provided. The filter element (219;319;519;619;719;819) includes a porous body (220;320;520;620;720;820) for at least mechanically filtering fluid flowing into the filter element (219;319;519;619;719;819) through at least one first surface area of the filter element (219;319;519;619;719;819), through the porous body (220;320;520;620;720;820) and out through at least one second surface area of the filter element (219;319;519;619;719;819). The filter element (219;319;519;619;719;819) includes a rim (221;321;521;621;721;821), covering at least a peripheral face of the porous body (220;320;520;620;720;820) so as to frame the first and second surface areas. The filter element (219;319;519;619;719;819) is combined with the cartridge housing part (212;312;512;612;712;812) so as to close at least one of the at least one openings (218;318;518;618;718;818) by bonding the rim (221;321;521;621;721;821) to the cartridge housing part (212;312;512;612;712;812).
Patent AU-2013276273-A1 (AU)
Title: Apparatus
Inventor: MCINTOSH KIRSTY
IPC: A61B5/145
Filed: 2013-06-11
Abstract: The present invention relates to a pH sensor adapted to be inserted into all soft tissues, such as muscle, fat or other organs e.g. heart, lung, kidney, liver, pancreas, renal gland etc., comprising one or more of: a) means to provide sensor calibration performance information; b) a sensor dislodgement alert, providing an indication to the user if the pH reading falls outside a predetermined range; c) an alert to indicate that the sensor has exceeded its usage period; and d) an alert to indicate that the sensor had exceeded its shelf life. There is also provided a method of assessing the efficacy of a treatment regime comprising the steps of determining any change in the pH of the soft tissue during treatment, where any change in the pH towards the preferred range for the tissue type is indicative of an effective treatment regime and any change in the pH away from the preferred range for the tissue type is indicative of a worsening in the condition of the tissue, and thus an ineffective treatment regime.
Patent AU-2013288253-A1 (AU)
Title: System and method for controlling operation of a metal-air battery
Inventor: YADGAR AVRAHAM
IPC: H01M10/44
Filed: 2013-07-09
Abstract: A system and method for controlling operation a metal-air battery are provided. A system and method for controlling operation a metal-air battery may include controlling a current drawn from the battery; and controlling a temperature of the battery. A system and method may draw a preconfigured amount of power from a metal-air battery, and draw power from a rechargeable device when power required is greater than the preconfigured power.
Patent AU-2013302861-A1 (AU)
Title: Treatment and diagnosis of melanoma
Inventor: TAVAZOIE SOHAIL
IPC: A61K38/17
Filed: 2013-08-13
Abstract: The present invention discloses novel agents and methods for diagnosis and treatment of melanoma. Also disclosed are related arrays, kits, and screening methods.
Patent AU-2013308739-A1 (AU)
Title: Biodegradable compositions, methods and uses thereof
Inventor: MOSELEY BRIAN HUGH
IPC: A41D19/00
Filed: 2013-08-29
Abstract: Disclosed herein are biodegradable compositions, materials, gloves and methods thereof.
Patent AU-2013331496-A1 (AU)
Inventor: LEONARD KRISTI A
IPC: C07D401/14
Filed: 2013-10-15
Abstract: The present invention comprises compounds of Formula (I), wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating ROR?t activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.
Patent AU-2013345495-A1 (AU)
Title: Automatic document feeder
Inventor: LEITMANN MIGUEL
IPC: H04N1/00
Filed: 2013-11-13
Abstract: This invention involves an automatic document feeder composed of a transparent sliding platform (1), side guides (3), longitudinal guides (7) and a horizontal guide (2), a system of springs (9), a controller (22), a linear actuator (4), a protection bar (12), a rigid part (11), a set of bushings, bearings (20), document detection and motion sensors, (13) and an end position sensor (10), a linear spring (14), a bobbin (5) and a motor (6). The invention can be adapted to all types of document reader (21) and reads flat and bulky documents alike. The invention also includes the operating method of the automatic document feeder.
Patent AU-2013352024-A1 (AU)
Title: Synergistic combination of lenacil and IPBC for dry film protection
Inventor: DONNELLY KENNETH M
IPC: A01P1/00
Filed: 2013-11-29
Abstract: A synergistic antimicrobial composition containing lenacil and 3-iodine-2-propenylbutylcarbamate is provided. Also provided is a method of inhibiting the growth of or controlling the growth of microorganisms in a building material by adding such a synergistic antimicrobial composition. Also provided is a coating composition containing such a synergistic antimicrobial composition, and a dry film made from such a coating composition.
Patent AU-2013369356-A1 (AU)
Title: Emulsifier system
Inventor: PIPE CHRISTOPHER JAMES
IPC: A23L29/10
Filed: 2013-12-23
Abstract: The invention relates to emulsifier systems which may be used for stabilizing the interface between a fat phase and an aqueous phase of a food product. The emulsifier system comprises coffee particles having a particle size in the range of from about 0.1 µm to about 500µm, preferably from 1µm to 200µm. The invention also relates to food products using such an emulsifier system, and to methods for the manufacture of such food products.
Patent AU-2014200704-A1 (AU)
Title: Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
Inventor: SEYER JEFFERY J
IPC: A61K9/20
Filed: 2014-02-10
Abstract: Sodium Ibuprofen Tablets And Methods Of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen Abstract The invention broadly relates to sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The formulation is advantageous because it allows for the formation of tablets having low sodium content and further provides tablets exhibiting improved physical stability, high tablet hardness and high strength, coupled with excellent dissolution and bioavailability characteristics. The formulations and processes are further advantageous because they can be produced in large quantities without an unacceptable number of defective tablets.
Patent AU-2014200957-A1 (AU)
Title: Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
Inventor: ROSSI JOHN J
IPC: A61K48/00
Filed: 2014-02-24
Abstract: The invention is directed to compositions and methods for selectively reducing the expression of a gene product from a desired target gene in a cell, as well as for treating diseases caused by the expression of the gene. More particularly, the invention is directed to compositions that contain double stranded RNA ('dsRNA'), and methods for preparing them, that are capable of reducing the expression of target genes in eukaryotic cells. The dsRNA has a first oligonucleotide sequence that is between 25 and about 30 nucleotides in length and a second oligonucleotide sequence that anneals to the first sequence under biological conditions. In addition, a region of one of the sequences of the dsRNA having a sequence length of at least 19 nucleotides is sufficiently complementary to a nucleotide sequence of the RNA produced from the target gene to trigger the destruction of the target RNA by the RNAi machinery.
Patent AU-2014202190-A1 (AU)
Title: New Stable Formulations of Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor Fusion Protein
Inventor: BOCK JASON BENJAMIN
IPC: A61K47/48
Filed: 2014-04-22
Abstract: Described herein are compositions and methods for treating, preventing and ameliorating diseases and conditions characterized by a lower than normal white blood cell count, such as leukopenia and neutropenia. The compositions and methods include recombinant human albumin-human granulocyte colony stimulating factor. Pharmaceutical formulations including the recombinant fusion protein, and methods of making such formulations are also described. Effects of Concentrations on rHSA-G-CSF 100, 95: 0 50 100 150 200 250 Concentration (mglml)
Patent AU-2014204736-A1 (AU)
Title: Reactive medium comprising a porous substrate impregnated with an organic compound capable of forming gas clathrates, and use thereof for separating and storing CO2
Inventor: TORRE JEAN-PHILIPPE STEPHANE
IPC: B01D53/02
Filed: 2014-01-14
Abstract: The invention relates to a reactive medium comprising a porous substrate on which is deposited, in solid form, an organic compound capable of forming gas clathrates. The invention also relates to a process for separating CO
Patent AU-2014233615-A1 (AU)
Title: Anti-N3pGlu Amyloid Beta Peptide Antibodies And Uses Thereof
Inventor: LU JIRONG
IPC: G01N33/577
Filed: 2014-09-26
Abstract: The present invention provides anti-N3pGlu AP antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the anti-N3pGlu AP antibodies or antigen-binding fragment thereof for the treatment of Alzheimer's disease.
Patent AU-2014238363-A1 (AU)
Title: Methods and acellular compositions for treating inflammatory disorders
Inventor: WOODELL-MAY JENNIFER E
IPC: A61P25/00
Filed: 2014-02-14
Abstract: Acellular compositions for treating inflammation, comprising two or more of IL1-ra, sTNF-R1, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-β1, and sIL-1RII. Components of the acellular compositions may be derived from biologic materials, such as blood clots and urine. Components may also be obtained from cell cultures.
Patent AU-2014262175-A1 (AU)
Title: Automatic shock absorber system for bicycle
Inventor: CHEN CHIEN-HUNG
IPC: B62K25/00
Filed: 2014-11-11
Abstract: An automatic control shock absorber system for a bicycle is provided. The system includes one or more sensors. A controller outputs a control signal to a damping adjuster according to the one or more sensors, such that the damping adjuster controls level of damping force based on the sensors.. Page 1 of 35 '-I\ c0
Patent AU-2014275772-A1 (AU)
Title: Malaria vaccine
Inventor: UENO RYUJI
IPC: C07K14/18
Filed: 2014-06-02
Abstract: The present invention provides a particle comprising a polypeptide and at least one malaria antigen, and a composition or vaccine comprising thereof, its use in medicine, particularly in the prevention or treatment of malaria infections.
Patent AU-2014300419-A1 (AU)
Title: Preform injection molding device
Inventor: TOYODA TAMOTSU
IPC: B29C45/26
Filed: 2014-05-15
Abstract: This injection molding device has a nozzle (1) for injection molding a biaxial stretch blow molding preform in which at least one intermediate layer is laminated in a base layer. An inner flow channel (15) and an outer flow channel (17) for forming the base layer and a middle flow channel (16) for forming the intermediate layer are disposed coaxially. The middle flow channel (16) is divided into a specified number of flow channels by longitudinal blocking rib pieces (20). The respective upstream portions (20b) of the side walls located on the upstream side of the pairs of side walls (20a) on the two sides of the longitudinal blocking rib pieces (20) in the circumferential direction are inclined surfaces for which the distance therebetween narrows from the downstream side to the upstream side, or the downstream ends of the longitudinal blocking rib pieces (20) enter the inner flow channel (15) and/or the outer flow channel (17).
Patent AU-2014332231-A1 (AU)
Title: Spinal implant system and method for lumbar and lumbosacral fusion
Inventor: WAUGH LINDSEY G
IPC: A61F2/44
Filed: 2014-10-03
Abstract: A surgical instrument comprises a first member engageable with tissue of a substantially posterior portion of an incision relative to a body. A second member is engageable with tissue of a substantially anterior portion of the incision relative to the body. A third member is engageable with tissue of a substantially cephalad portion of the incision relative to the body. The members are disposable in a configuration to space the tissue to define an oblique surgical pathway relative to a bilateral axis of the body. Systems and methods are disclosed.
Patent AU-2014369422-A1 (AU)
Title: Railway points, railway points operating apparatus and railway track crossing
Inventor: BEMMENT SAMUEL DAVID
IPC: B61L5/02
Filed: 2014-12-17
Abstract: A railway points arrangement (10) for a railway track junction comprises at least first and second pairs of longitudinally-extending, parallel-spaced static stock rails (12), (14), defining respectively a first route and a second route, and a pair of longitudinally- extending, parallel-spaced switch rails (16) which are movable between a first position in alignment with the first pair of stock rails (12) to select the first route and a second position in alignment with the second pair of stock rails (14) to select the second route. At least one of the movable switch rails (16a) cooperates with at least one stock rail (12), (14) of each of the first and second pairs of stock rails (12), (14) when the movable switch rails (16) are in the first and second positions, and the at least one switch rail (16) and the at least one stock rail (12), (14) are shaped to define a mating profile (50) which aligns the switch rail (16) and stock rail (12), (14) and prevents transverse movement of the switch rail (16) relative to the stock rail (12), (14).
Patent AU-2015201039-A1 (AU)
Title: Fourier domain mode locking
Inventor: FUJIMOTO JAMES
IPC: G01N21/47
Filed: 2015-02-27
Abstract: A system for reducing a repetition time of a frequency swept waveform, the system comprising: a laser, comprising a gain medium disposed within an optical cavity; a modulation means configured to modulate a gain medium of the laser, the laser and the gain medium configured to generate a unidirectional frequency sweep waveform having a repetition time; a separating optical element configured to separate the unidirectional frequency sweep waveform into at least two portions; a delay optical element configured to introduce a time delay between the at least two portions; a recombination optical element configured to recombine the at least two portions upon introduction of the time delay, and at least one polarization controller to control the polarization of at least one of the two portions of the frequency sweep waveform; wherein the time delay introduced by the optical delay element is selected so that the recombination optical element recombines the at least two portions of the unidirectional frequency sweep waveform substantially without an overlap, and further wherein the separating optical element, the delay optical element and the recombination optical element are disposed outside of the optical cavity. H:\mka\Interwoven\NRPortbl\DCC\MKA\7512099_1.docx - 27/2/15 WO 2010/047936 PCT/US20091'059324 I' CD (WThlD "I cc)~ JEUBLISJOIJI0 0.) 0 = ;eub3~s 10)JU03 to .aq qun a4 C)0
Patent AU-2015201452-A1 (AU)
Title: Method and apparatus for encoding residual block, and method and apparatus for decoding residual block
Inventor: CHEON MIN-SU
IPC: H04N7/24
Filed: 2015-03-19
Abstract: Methods and apparatuses for encoding and decoding a residual block are provided. The method of encoding the residual block includes: generating a prediction block of a current block; generating a residual block based on a difference between the prediction block and the current block; generating a transformation residual block by transforming the residual block to a frequency domain; splitting the transformation residual block into frequency band units; and encoding effective coefficient flags indicating frequency band units, of the frequency band units, in which nonzero effective transformation coefficients exist.
Patent AU-2015202164-A1 (AU)
Title: Optical sensor and manufacturing method thereof
Inventor: YU TENG-CHIEN
IPC: G02B6/42
Filed: 2015-04-27
Abstract: Some embodiments of the present disclosure provide an optical sensor. The optical sensor includes a semiconductive block having a front side and a back side, a wave guide region, and a light sensing region. The wave guide region is positioned over the back side of the semiconductive block and having a core layer. The wave guide region is configured to guide an incident light. The light sensing region is positioned in the semiconductive block, having a multi-junction photodiode. The light sensing region is configured to sense emission lights from the wave guide region. Cl l 000k Cl~ C/) COO